The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-(2-hydroxy-3-(4-methylpiperazin-1-yl)propyl)-9H-carbazole-3,6-dicarbonitrile ID: ALA5278886
Max Phase: Preclinical
Molecular Formula: C22H23N5O
Molecular Weight: 373.46
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(CC(O)Cn2c3ccc(C#N)cc3c3cc(C#N)ccc32)CC1
Standard InChI: InChI=1S/C22H23N5O/c1-25-6-8-26(9-7-25)14-18(28)15-27-21-4-2-16(12-23)10-19(21)20-11-17(13-24)3-5-22(20)27/h2-5,10-11,18,28H,6-9,14-15H2,1H3
Standard InChI Key: FJIYHDSBZHRWFS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
0.6880 -0.4862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8928 0.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3416 0.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4642 0.5847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0767 1.1361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0767 1.9606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7908 2.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5048 1.9606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5048 1.1361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7908 0.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6196 -0.0822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1042 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7688 -1.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9488 -1.5880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4641 -0.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7996 -0.1684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2536 -2.1692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6414 -2.7029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2193 2.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7905 2.7029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7001 0.3107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2513 -0.3030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0585 -0.1342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6082 -0.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3508 -1.5321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5437 -1.7008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9940 -1.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7905 -2.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 4 1 0
16 11 2 0
13 17 1 0
17 18 3 0
8 19 1 0
19 20 3 0
2 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 22 1 0
25 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.46Molecular Weight (Monoisotopic): 373.1903AlogP: 2.15#Rotatable Bonds: 4Polar Surface Area: 79.22Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.28CX LogP: 2.26CX LogD: 1.33Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.76Np Likeness Score: -1.14
References 1. Clausen JD, Kjellerup L, Cohrt KO, Hansen JB, Dalby-Brown W, Winther AL.. (2017) Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives., 27 (19): [PMID:28893470 ] [10.1016/j.bmcl.2017.08.067 ]